Argenx SE Sustainability Reports
Arxenx SE specializes in developing innovative antibody therapies for a range of severe autoimmune diseases and cancers.
Sector: Health Care
Country: Netherlands
Exchange: Euronext Brussels
ISIN: NL0010832176
16 reports from 2014 to 2025
Company Profile
Argenx SE
Arxenx SE specializes in developing innovative antibody therapies for a range of severe autoimmune diseases and cancers.
Reports